BioMarin Pharmaceutical | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 2.46B 312M 2025-04
Agios Pharmaceuticals USD 1.57B 303M 2025-04
Alnylam Pharmaceuticals USD 29.63B 5.49B 2025-04
Amgen USD 155.38B 15.41B 2025-04
Bayer EUR 20.62B 1.09B 2025-04
Biogen USD 17.08B 5.2B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Gilead Sciences USD 128.49B 11.2B 2025-04
Incyte USD 13.57B 1.85B 2025-04
Insmed USD 10.42B 1.96B 2025-04
Ionis Pharmaceuticals USD 4.49B 1.03B 2025-04
Moderna USD 9.83B 6.17B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
PTC Therapeutics USD 3.43B 77M 2025-04
Regeneron Pharmaceuticals USD 62.45B 6.89B 2025-04
Sarepta Therapeutics USD 5.03B 6.76B 2025-04
Ultragenyx Pharmaceutical USD 2.86B 1.03B 2025-04
United Therapeutics USD 14.04B 1.71B 2025-04
Vertex Pharmaceuticals USD 127.19B 23.74B 2025-04



BioMarin Pharmaceutical Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.